MRK
Merck & Co., Inc. · NYSE
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website merck.com
- Employees(FY) 67000
- ISIN US58933Y1055
Performance
+1.4%
1W
+2.64%
1M
+4.34%
3M
+28.78%
6M
+20.06%
YTD
+13.34%
1Y
Profile
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV, as well as a collaboration with Bionomics to identify novel a7 nAChR PAMs suitable for the treatment of cognitive disorder; and clinical trial collaboration and supply agreement with Ankyra Therapeutics to evaluate ANK-101 in combination with KEYTRUDA (pembrolizumab) in patients with advanced solid tumors, as well as a clinical trial collaboration and supply agreement with Phanes Therapeutics, Inc. to evaluate PT886 in combination with KEYTRUDA for the treatment of claudin 18.2 positive gastric or gastroesophageal junction adenocarcinomas, as well as a development and commercialization agreement with Daiichi Sankyo Company, Limited to jointly develop and commercialize Daiichi Sankyo's DXd antibody drug conjugate (ADC) candidates and a collaboration with HiberCell, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Investment Analysis Report: Merck & Co., Inc. (MRK)
Overview:
Merck & Co., Inc. (MRK) operates in the Health Technology sector, specifically in the Pharmaceuticals: Major industry. The company has a market capitalization of $328.03 billion. In this report, we will conduct a comprehensive analysis of MRK's financial statements to evaluate...
Technical Analysis of MRK 2024-05-10
Overview:
In the last 5 trading days, MRK stock has shown a mix of price movements with some volatility in the price action. By analyzing various technical indicators including trend, momentum, volatility, and volume, we can gain insights into the possible future price movement of MRK stock.
Trend Indicators:
- Moving Averages (MA): The 5-day Mov...
Recent News & Updates
- 2024-04-29 06:54
Dividend Stock Portfolio For Income: Top 5 Stocks(Insidermonkey)
- 2024-04-27 21:14
5 Best Long Term Low Risk Stocks to Buy(Insidermonkey)
- 2024-04-27 08:24
- 2024-04-26 10:59
- 2024-04-26 05:54
5 Best Growth Stocks To Invest In For the Next 5 Years(Insidermonkey)
- 2024-04-26 00:09
- 2024-04-25 23:42
- 2024-04-25 23:34
20 Fastest Growing Health Tech Companies in the World(Insidermonkey)
- 2024-04-25 22:54
- 2024-04-25 22:30
- 2024-04-25 21:13
- 2024-04-25 16:09
Analyst Report: Merck & Co., Inc.(Morningstar Research)
- 2024-04-25 15:30
Merck (MRK) Q1 2024 Earnings Call Transcript(Motley Fool)
- 2024-04-25 14:29
- 2024-04-25 12:52
- 2024-04-25 12:09
- 2024-04-25 11:34
20 Fastest Growing Health Tech Companies in the World(Insider Monkey)
- 2024-04-25 11:23
Merck raises 2024 guidance on cancer drug demand(Yahoo Finance Video)
- 2024-04-25 09:13
Merck Shares Climb After Higher-Than-Expected Sales of Cancer Drug Keytruda(The Wall Street Journal)
- 2024-04-25 09:00
We Think Merck (NYSE:MRK) Can Stay On Top Of Its Debt(Simply Wall St.)
- 2024-04-25 07:30
Meta, IBM sink on earnings, American Airlines and Caterpillar report: Yahoo Finance(Yahoo Finance Video)
- 2024-04-25 07:04
- 2024-04-25 06:44
Merck: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-04-25 06:33
- 2024-04-25 06:30
Merck Announces First-Quarter 2024 Financial Results(Business Wire)
- 2024-04-25 06:30
- 2024-04-24 18:30
Merck Announces First-Quarter 2024 Financial Results(Businesswire)
- 2024-04-24 17:50
Alphabet, Microsoft, Southwest earnings: What to watch(Yahoo Finance Video)
- 2024-04-24 10:09
- 2024-04-23 07:49
Here’s Why Merck & Co. (MRK) Outperformed in Q1(Insider Monkey)